vedolizumab

Elana Gotkine FRIDAY, March 31, 2023 (HealthDay News) -- For patients with chronic pouchitis after undergoing restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) for ulcerative colitis,…

This section is Partnership Content supplied The content in this section is supplied by Business Wire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content.…

More ulcerative colitis patients responded to vedolizumab (Entyvio) when they started it soon after their diagnosis rather than after other therapies, insurance claims…

Risk for Clostridioides difficile (C. diff) infection wasn't any greater with vedolizumab (Entyvio) versus anti-tumor necrosis factor (TNF) agents for ulcerative…

A topic widely discussed among physicians during the recent Digestive Disease Week virtual meeting was a large British cohort study that looked at the antibody…